These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9873952)

  • 1. Measurement of pS2 protein in pancreatic cyst fluids. Evidence for a potential role of pS2 protein in the pathogenesis of mucinous cystic tumors.
    Yang JM; Lee J; Southern JF; Warshaw AL; Dhanak E; Lewandrowski KB
    Int J Pancreatol; 1998 Dec; 24(3):181-6. PubMed ID: 9873952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
    Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
    Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
    Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of epidermal growth factor receptor and estrogen receptor-independent pS2 protein to the malignant transformation of mucinous cystic neoplasms of the pancreas.
    Kirby RE; Lewandrowski KB; Southern JF; Compton CC; Warshaw AL
    Arch Surg; 1995 Jan; 130(1):69-72. PubMed ID: 7802579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.
    Sperti C; Pasquali C; Guolo P; Polverosi R; Liessi G; Pedrazzoli S
    Cancer; 1996 Jul; 78(2):237-43. PubMed ID: 8673998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
    Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
    Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent Accuracy of Glucose Level in Cystic Fluid for Diagnosis of Pancreatic Mucinous Cysts.
    Faias S; Pereira L; Roque R; Chaves P; Torres J; Cravo M; Pereira AD
    Dig Dis Sci; 2020 Jul; 65(7):2071-2078. PubMed ID: 31705344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions.
    Centeno BA; Lewandrowski KB; Warshaw AL; Compton CC; Southern JF
    Am J Clin Pathol; 1994 Apr; 101(4):483-7. PubMed ID: 8160642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions.
    Panarelli NC; Sela R; Schreiner AM; Crapanzano JP; Klimstra DS; Schnoll-Sussman F; Pochapin MB; Yantiss RK
    Am J Surg Pathol; 2012 Oct; 36(10):1434-43. PubMed ID: 22982886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
    Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
    Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas.
    Hammel P; Levy P; Voitot H; Levy M; Vilgrain V; Zins M; Flejou JF; Molas G; Ruszniewski P; Bernades P
    Gastroenterology; 1995 Apr; 108(4):1230-5. PubMed ID: 7535275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
    J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts.
    Carr RA; Yip-Schneider MT; Simpson RE; Dolejs S; Schneider JG; Wu H; Ceppa EP; Park W; Schmidt CM
    Surgery; 2018 Mar; 163(3):600-605. PubMed ID: 29241991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of gastric mucins (M1 antigens) in cyst fluid for the diagnosis of cystic lesions of the pancreas.
    Hammel PR; Forgue-Lafitte ME; Lévy P; Voitot H; Vilgrain V; Fléjou JF; Molas G; Gespach C; Ruszniewski P; Bernades P; Bara J
    Int J Cancer; 1997 Jun; 74(3):286-90. PubMed ID: 9221806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
    Linder JD; Geenen JE; Catalano MF
    Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.
    Talar-Wojnarowska R; Pazurek M; Durko L; Degowska M; Rydzewska G; Smigielski J; Janiak A; Olakowski M; Lampe P; Grzelak P; Stefanczyk L; Smolarz B; Malecka-Panas E
    Pancreatology; 2012; 12(5):417-20. PubMed ID: 23127529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.